Refractory Mycosis Fungoides/Sezary Syndrome Completed Phase 2 Trials for Interferon gamma-1b (DB00033)

Also known as: Mycosis fungoides/Sezary syndrome refractory / Refractory Mycosis Fungoides and Sezary Syndrome / Cutaneous T-cell lymphoma refractory

IndicationStatusPhase
DBCOND0126278 (Refractory Mycosis Fungoides/Sezary Syndrome)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03063632Testing the Combination of Two Experimental Drugs MK-3475 (Pembrolizumab) and Interferon-gamma for the Treatment of Mycosis Fungoides and S├ęzary Syndrome and Advanced Synovial SarcomaTreatment